DNA Methylation as a Biomarker for Monitoring Disease Outcome in Patients with Hypovitaminosis and Neurological Disorders

DNA methylation remains an under-recognized diagnostic biomarker for several diseases, including neurodegenerative disorders. In this study, we examined differences in global DNA methylation (5mC) levels in serum samples from patients during the initial- and the follow-up visits. Each patient underw...

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Iglesias, Olaia, Naidoo, Vinogran, Corzo, Lola, Pego, Rocío, Seoane, Silvia, Rodríguez, Susana, Alcaraz, Margarita, Muñiz, Adriana, Cacabelos, Natalia, Cacabelos, Ramón
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956161/
https://www.ncbi.nlm.nih.gov/pubmed/36833292
http://dx.doi.org/10.3390/genes14020365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9956161/
https://www.ncbi.nlm.nih.gov/pubmed/36833292
http://dx.doi.org/10.3390/genes14020365

Ejemplares similares